Antibody response to pneumococcal polysaccharide vaccine in systemic sclerosis

Journal of Rheumatology

Volumn 36, Issue 7, 2009, Pages 1549-1550

  Mercado, Ulises ^a   Acosta, Hector ^a   Diaz Molina, Raul ^a  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CENTROMERE ANTIBODY; COLCHICINE; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE; METOCLOPRAMIDE; PENICILLAMINE; PNEUMOCOCCUS VACCINE; PREDNISONE; PROTON PUMP INHIBITOR; PULMOVAX; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOGENICITY; LETTER; LOW DRUG DOSE; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VACCINATION;

ADULT; ANTIBODIES; ANTIBODIES, BACTERIAL; CENTROMERE; DNA TOPOISOMERASES, TYPE I; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES; SCLERODERMA, SYSTEMIC;

EID: 67650478329     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081227     Document Type: Letter

References (11)

1. Silver RM, Miller KS. Lung involvement in systemic sclerosis. Rheum Dis Clin N Am 1990;16:199-216.
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1977;45:1-24.
3. Whitney CG. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age ? 65. Geriatrics 2003;58:20-2; 25.
4. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
5. LeRoy EC, Krieg T, Black CM, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988;15:202-5.
6. Mercado U. Antibody responses following vaccination in lupus patients. Rev Invest Clin 2003;55:93-4.
7. Mercado U. Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus [editorial]. J Rheumatol 2006;33:1469-71.
8. Elkayam O, Paran D, Burke M, et al. Pneumococcal vaccination of patients with systemic lupus erythematosus: Effects on generation of autoantibodies. Autoimmunity 2005:38:493-6.
9. Mease PJ, Ritchlin CT, Martin RW, et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31:1356-61.
10. Arnett FC. Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol 2006;18:579-81.
11. Hudson M, Steele R; Canadian Scleroderma Research Group (CSRG), Baron M. Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum 2007;37:93-8.